Table 3

Patient characteristics for 12 AML patients for RT-PCR

SampleAge/sexPrimary/secondaryDe novo/relapsedCytogeneticsFlt-3 ITD% CD34FABNotes
53/F Primary Relapsed 46, XX, t(5;15;12;12) Unknown 50 M5  
56/M Secondary De novo 45, XY, t(8;9)(q24;q22),-21 Negative 52 NS Secondary to chronic eosinophilic leukemia 
47/M Primary De novo Normal Negative 68 M5  
40/F Primary De novo Normal Normal 90 M5  
77/F Primary De novo 46, XX, der(7)t(1;7)(q25;q31.2) Negative 87 M4 FLT3 TKD positive 
59/M Primary De novo Normal Positive 18 NS  
64/M Primary De novo Normal Positive M1  
39/M Primary Relapsed Normal Positive 27 M4 NPM positive 
61/F Primary De novo 46, XX, t(10;11)(p11.2–12;q23) Negative M5 MLL positive 
10 39/F Primary De novo Normal Positive M4 NPM positive 
11 57/F Primary De novo Normal Negative M5 NPM positive 
12 46/M Primary De novo Failed to grow Negative 98 M5 FISH negative for monosomy 5,7 and trisomy 8 
SampleAge/sexPrimary/secondaryDe novo/relapsedCytogeneticsFlt-3 ITD% CD34FABNotes
53/F Primary Relapsed 46, XX, t(5;15;12;12) Unknown 50 M5  
56/M Secondary De novo 45, XY, t(8;9)(q24;q22),-21 Negative 52 NS Secondary to chronic eosinophilic leukemia 
47/M Primary De novo Normal Negative 68 M5  
40/F Primary De novo Normal Normal 90 M5  
77/F Primary De novo 46, XX, der(7)t(1;7)(q25;q31.2) Negative 87 M4 FLT3 TKD positive 
59/M Primary De novo Normal Positive 18 NS  
64/M Primary De novo Normal Positive M1  
39/M Primary Relapsed Normal Positive 27 M4 NPM positive 
61/F Primary De novo 46, XX, t(10;11)(p11.2–12;q23) Negative M5 MLL positive 
10 39/F Primary De novo Normal Positive M4 NPM positive 
11 57/F Primary De novo Normal Negative M5 NPM positive 
12 46/M Primary De novo Failed to grow Negative 98 M5 FISH negative for monosomy 5,7 and trisomy 8 

Twelve patients were screened by RT-PCR for NuSAP1 and CHAF1b gene expression analysis. The patient characteristics are described.

RT-PCR indicates reverse transcription–polymerase chain reaction; TKD, tyrosine kinase domain; NPM, nucleophosmin; FAB, French-American-British; MLL, mixed lineage leukemia; and FISH, fluorescence in situ hybridization.

or Create an Account

Close Modal
Close Modal